Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?

Academic Article

Abstract

  • © Lippincott Williams & Wilkins. The 2015 Centers for Disease Control Sexually Transmitted Disease treatment guidelines currently recommend a single 2-g dose of oral metronidazole as the preferred regimen for treatment of trichomoniasis in human immunodeficiency virus (HIV)-negative women. Mounting recent evidence has shown that the 7-day oral metronidazole dosing regimen is more efficacious than the single 2-g dose. This commentary reviews the implications associated with these new data and discusses issues surrounding it that should be considered moving forward.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Muzny CA; Richter S; Kissinger P
  • Start Page

  • E57
  • End Page

  • E59
  • Volume

  • 46
  • Issue

  • 5